Table 2.
Primary and secondary outcomes of patients in the M and MF groups.
| M(n = 40) | MF(n = 40) | p | |
|---|---|---|---|
| Intraoperative N/V | 10 (25.0%) | 2 (5.0%) | 0.028 |
| N/R/V | 8/1/1 | 2/0/0 | |
| Postoperative N/V | 8 (20.0%) | 2 (5.0%) | 0.091 |
| N/R/V | 8/0/0 | 2/0/0 | |
| Use of antiemetics | 9 (22.5%) | 0 (0%) | 0.005 |
| Intraoperative/Postoperative | 8/1 | 0/0 | |
| Patients with ephedrine injected | 17 (42.5%) | 13 (32.5%) | 0.488 |
| Ephedrine (mg) | 3.8 ± 4.9 | 3.0 ± 4.8 | 0.460 |
| Five-point satisfaction score | 3.4 ± 0.9 | 4.2 ± 0.7 | <0.001 |
Data are expressed as the mean ± standard deviation, number of patients (n), or n (%). Abbreviations: M, midazolam; MF, midazolam plus fentanyl; N, nausea; R, retching; V, vomiting.